KeyBanc raised the firm’s price target on Corteva to $63 from $62 and keeps an Overweight rating on the shares. The firm came away from Corteva’s Q4 results with greater confidence in an earnings recovery in 2024, and overall a healthier outlook for crop protection after a tough 2023, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CTVA:
